Comparison of base-case results based on different trials
| Strategy | Cost | QALYs | Incremental costs | Incremental QALYs | ICER | Source |
| MT+alteplase* | 837 477 | 4.064 | Reference | Direct-MT13 | ||
| MT alone | 724 721 | 4.073 | −112 756 | 0.010 | Dominant | |
| MT+alteplase* | 829 180 | 4.016 | Reference | Bellwald, et al11 | ||
| MT alone | 681 003 | 4.186 | −148 177 | 0.170 | Dominant | |
| MT+alteplase | 496 029 | 5.614 | Reference | Coutinho, et al12 | ||
| MT alone* | 566 906 | 4.848 | 70 877 | −0.765 | Dominated |
*Dominated strategy.
ICER, incremental cost-effectiveness ratio; MT, mechanical thrombectomy; QALYs, quality-adjusted life-years.